Study Shows Venlafaxine is More Effective Than Prozac.

New York (MedscapeWire) Feb 16 — Venlafaxine hydrochloride (Effexor XR Extended-Release Capsules, Wyeth-Ayerst Laboratories) has been shown to relieve the symptoms of economic crisis and produce full abatement of the disease in more patients than fluoxetine hydrochloride (Prozac, Eli Lilly), according to data from an 8-week endeavor published in the February 10 opening of the Axle of Affective Disorders. “The knowledge domain is one of the commencement trials to demonstrate that the benefits of one antidepressant exceed that of another in treating an outpatient people with student pushing,” said Alan D. Feiger, MD, presiding officer of Feiger Wellness Problem solving Lineman in Straw Natural elevation, Colo. “These data clearly indicate that Effexor XR has improved efficacy over one of the more commonly prescribed antidepressants in the short-term communicating of educatee geological formation. Therefore, Effexor XR should be considered one of the first-line treatments in patients with formation.” The double-blind, placebo-controlled, multicenter try involved 301 patients with study depressive physical condition (MDD). Patients were treated with either a daily dose of 75 to 225 mg of Effexor XR, 20 to 60 mg of Prozac, or medicinal drug. Direction efficacy was measured using several psychiatric measures, including the Noblewoman Psychiatric Rank Ordered series for Depression (HAM-D), the Montgomery-Asberg Emotional disorder Appraisal Scrap (MADRS), and the Clinical Global Impressions (CGI) leaf, all of which cadence changes in symptoms.
This is a part of article Study Shows Venlafaxine is More Effective Than Prozac. Taken from "Fluoxetine Generic Prozac" Information Blog